The FDA poses a deadly threat to the health of Americans - the very organization that is meant to protect them. Despite a significant decrease in smoking rates over the past decade, bureaucratic efforts aimed at building the FDA empire are now working to reverse this trend.
The US Food and Drug Administration (FDA) has ordered Juul, a popular electronic cigarette manufacturer, to cease sales of its products. Juul has been widely regarded as the most effective product designed to help smokers quit their addiction to cigarettes. The FDA has also proposed limiting nicotine levels in traditional cigarettes – a method that has proven ineffective in the past, leading smokers to obtaining nicotine through more dangerous means, such as smoking more cigarettes or purchasing high-strength tobacco products on the black market.
A federal judge has suspended the ban on Juul products, which was implemented in response to concerns about their impact on public health. The move has been criticized for going against both public health principles and political wisdom; why would millions of voters be deprived of e-cigarettes in an election year? According to the FDA, it has been unable to identify any direct dangers posed by Juul products to the public. The FDA also claims that Juul has not provided sufficient safety information, but this assertion is questionable given that the company spent over $100 million on its application to the FDA. Moreover, focusing on the slight unknown risks of e-cigarettes is foolish; UK public health authorities estimate that e-cigarettes are 95% less harmful than traditional cigarettes.
The ban only makes sense to bureaucrats and special interests who perceive an e-cigarette threat. E-cigarettes offer many benefits of nicotine - weight control, improved attention and cognitive performance, reduced anxiety, and enhanced mood - without the thousands of toxins found in traditional cigarettes. Like caffeine, nicotine can be habit-forming and can cause a temporary, mild increase in blood pressure. As summarized by the Royal Society for Public Health, both are "fairly harmless.
Anti-e-cigarette activists and their supporters at the FDA claim that e-cigarettes are a gateway for youth smoking, but in the age of e-cigarettes, the rate of youth smoking has decreased much faster than in previous years. Ten years ago, when e-cigarettes were introduced, 13% of high school students smoked; today, that number is less than 2%.
No one wants to see teenagers become addicted to nicotine, but purchasing e-cigarettes is already illegal. Research indicates that in the past two years, the rate of e-cigarette use among high school students has sharply declined. Moreover, most e-cigarette users in this age group only use the devices occasionally, and typically not with nicotine. (Most of them report using e-cigarettes to inhale marijuana, but the FDA has not banned the sale of marijuana to adults on this basis.)
In the era of vaping, smoking rates among adults have sharply declined, particularly since the introduction of Juul, with obvious benefits for health. A recent study tracked over 30,000 Americans for six years and found that e-cigarette users had a one-third lower incidence of cardiovascular disease compared to smokers, with no difference in incidence compared to those who neither smoke cigarettes nor use e-cigarettes.
Other studies suggest that electronic cigarettes are more effective than other nicotine replacement therapies, such as nicotine patches or gum, in helping smokers quit. Even smokers who do not intend to quit can increase their chances of quitting if they use an e-cigarette at least once a day. Juul has been particularly successful because it provides a high dose of nicotine in a fast-absorbing form, similar to tobacco cigarettes. One study found that 50% of Juul users quit smoking within a year, while another shows that smokers who use the full-strength Juul, rather than the lower nicotine content version, are more likely to quit.
This is good news for public health, but bad news for companies that market smoking cessation products with low efficiency, as well as activists, scholars, and bureaucrats dedicated to anti-smoking efforts. With so many Americans using electronic cigarettes to quit smoking, how can anti-smoking activists justify their work? There is also a significant financial component: the US Food and Drug Administration annually collects more than $800 million from tobacco use fees, which should be aimed at reducing the harm of tobacco products to improve health.
In order to maintain a steady flow of funding, bureaucrats have misguidedly labeled electronic cigarettes as "tobacco products" and set new goals to eliminate nicotine. Since the start of the anti-vaping movement, the FDA’s Center for Tobacco Products has more than doubled its staff to over 1,100 employees, distributing billions of dollars in external grants each year, with a significant portion going towards non-profit organizations spreading anti-vaping messages and researchers advocating for nicotine bans.
Unfortunately, with the help of mainstream journalists, the FDA's misguided campaign has been successful. They have blamed deaths on electronic cigarettes to be caused by black-market THC products, creating a moral panic. In the early days of the e-cigarette era, most Americans saw them as a safer alternative to tobacco cigarettes. However, subsequent investigations led many to believe that e-cigarettes were just as dangerous, if not more so. This erroneous belief could lead many smokers to shorter lifespans.
Banning nicotine is an unrealistic and pointless goal. The issue of teenage smoking pales in comparison to alcohol abuse, but we know that prohibiting the sale of alcohol to adults would create more problems than it solves. This holds true for electronic cigarettes as well. If the FDA successfully bans products like Juul, Americans will only return to smoking or turn to the black market for less safe e-cigarette devices.
According to Michael Siegel, a researcher in tobacco control at Tufts University, "At least four million smokers have successfully quit smoking by using e-cigarettes and still rely on these products to stay away from cigarettes." He has been studying tobacco control for thirty years. "If the FDA doesn't approve most e-cigarettes, the ultimate result will be a public health tragedy, with a large number of former smokers returning to smoking.
In the FDA's fantasy world, once the nicotine levels in cigarettes decrease to a "non-addictive" level, smokers will be saved. Last week, the agency announced plans to limit nicotine levels in all cigarettes, even declaring that very low nicotine cigarettes are "appropriate for protecting public health." As pointed out by Dr. Brad Rodu, a medical professor at the University of Louisville, this is a strange endorsement of a deadly product, especially considering that low-nicotine cigarettes in the past have failed to help smokers quit.
Rodu, a contributor to the Tobacco Truth blog, stated, "If the FDA only allows low-nicotine cigarettes, it sets up the perfect black market." The FDA has already banned Juul, which was the only successful cigarette alternative for millions of American adult smokers. These illogical actions will not have any effect on the annual 500,000 smoking-related deaths in the US, or may even lead to an increase in mortality rates.
Currently, the best hope for sensible policy lies outside of the FDA. Perhaps the courts will protect Juul from the FDA's foolish actions, or politicians up for re-election will stand up for voters who enjoy nicotine. However, as long as the FDA and its $800 million tobacco fee remain under the control of anti-nicotine zealots, it will continue to harm the health of Americans.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
